205 related articles for article (PubMed ID: 15975509)
1. Dissecting RNA-interference pathway with small molecules.
Chiu YL; Dinesh CU; Chu CY; Ali A; Brown KM; Cao H; Rana TM
Chem Biol; 2005 Jun; 12(6):643-8. PubMed ID: 15975509
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric RNA duplexes mediate RNA interference in mammalian cells.
Sun X; Rogoff HA; Li CJ
Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911
[TBL] [Abstract][Full Text] [Related]
3. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
Yoo JW; Kim S; Lee DK
Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
[TBL] [Abstract][Full Text] [Related]
4. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
[TBL] [Abstract][Full Text] [Related]
5. RNAi: RISC gets loaded.
Preall JB; Sontheimer EJ
Cell; 2005 Nov; 123(4):543-5. PubMed ID: 16286001
[TBL] [Abstract][Full Text] [Related]
6. [Great potential of small RNAs: RNA interference and microRNA].
Vázquez-Ortiz G; Piña-Sánchez P; Salcedo M
Rev Invest Clin; 2006; 58(4):335-49. PubMed ID: 17146945
[TBL] [Abstract][Full Text] [Related]
7. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
[TBL] [Abstract][Full Text] [Related]
8. Illuminating the silence: understanding the structure and function of small RNAs.
Rana TM
Nat Rev Mol Cell Biol; 2007 Jan; 8(1):23-36. PubMed ID: 17183358
[TBL] [Abstract][Full Text] [Related]
9. Induction and biochemical purification of RNA-induced silencing complex from Drosophila S2 cells.
Caudy AA; Hannon GJ
Methods Mol Biol; 2004; 265():59-72. PubMed ID: 15103068
[TBL] [Abstract][Full Text] [Related]
10. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
11. Suppression of RNA interference by adenovirus virus-associated RNA.
Andersson MG; Haasnoot PC; Xu N; Berenjian S; Berkhout B; Akusjärvi G
J Virol; 2005 Aug; 79(15):9556-65. PubMed ID: 16014917
[TBL] [Abstract][Full Text] [Related]
12. Focusing on RISC assembly in mammalian cells.
Hong J; Wei N; Chalk A; Wang J; Song Y; Yi F; Qiao RP; Sonnhammer EL; Wahlestedt C; Liang Z; Du Q
Biochem Biophys Res Commun; 2008 Apr; 368(3):703-8. PubMed ID: 18252196
[TBL] [Abstract][Full Text] [Related]
13. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
14. Inputs and outputs for chromatin-targeted RNAi.
Chan SW
Trends Plant Sci; 2008 Jul; 13(7):383-9. PubMed ID: 18550415
[TBL] [Abstract][Full Text] [Related]
15. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
Akhtar S; Benter I
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
[TBL] [Abstract][Full Text] [Related]
16. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC
Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199
[TBL] [Abstract][Full Text] [Related]
17. Short interfering RNA strand selection is independent of dsRNA processing polarity during RNAi in Drosophila.
Preall JB; He Z; Gorra JM; Sontheimer EJ
Curr Biol; 2006 Mar; 16(5):530-5. PubMed ID: 16527750
[TBL] [Abstract][Full Text] [Related]
18. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
19. Local RNA target structure influences siRNA efficacy: a systematic global analysis.
Overhoff M; Alken M; Far RK; Lemaitre M; Lebleu B; Sczakiel G; Robbins I
J Mol Biol; 2005 May; 348(4):871-81. PubMed ID: 15843019
[TBL] [Abstract][Full Text] [Related]
20. State-of-the-art modified RNAi compounds for therapeutics.
Carstea ED; Hough S; Wiederholt K; Welch PJ
IDrugs; 2005 Aug; 8(8):642-7. PubMed ID: 16044372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
